Differential Expression in Markers for Thrombin, Platelet Activation, and Inflammation in Cell Saver Versus Systemic Blood in Patients Undergoing On-Pump Coronary Artery Bypass Graft Surgery

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 21, Issue 4, 2007, Pages 519-523

  Takayama, Hiroo ^a   Soltow, Louise O ^a   Aldea, Gabriel S ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

cardiopulmonary bypass; hemolysis; inflammation; processed cell saver blood

Indexed keywords

BETA THROMBOGLOBULIN; BIOLOGICAL MARKER; ELASTASE; HEMOLYTIC AGENT; INTERLEUKIN 6; INTERLEUKIN 8; NEURON SPECIFIC ENOLASE; PROTEIN S100B; PROTHROMBIN; THROMBIN;

ADULT; AGED; ARTERIAL BLOOD; ARTICLE; BLOOD CONSERVATION; BLOOD SAMPLING; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOLYSIS; HUMAN; INFLAMMATION; MALE; NEUTROPHIL; OBSERVATIONAL STUDY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROCESSED CELL SAVER BLOOD; PROSPECTIVE STUDY; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; STUDENT T TEST; THROMBOCYTE ACTIVATION;

BETA-THROMBOGLOBULIN; BIOLOGICAL MARKERS; CORONARY ARTERY BYPASS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HEMOLYSIS; HUMANS; INFLAMMATION; INTERLEUKIN-6; INTERLEUKIN-8; LEUKOCYTE ELASTASE; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PEPTIDE FRAGMENTS; PHOSPHOPYRUVATE HYDRATASE; PLATELET ACTIVATION; PROSPECTIVE STUDIES; PROTHROMBIN; THROMBIN; TREATMENT OUTCOME;

EID: 34547166977     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2007.01.020     Document Type: Article

References (36)

1. Borowiec J.W., Bozdayi M., Jaramillo A., et al. Influence of two blood conservation techniques (cardiotomy reservoir versus cell-saver) on biocompatibility of the heparin-coated cardiopulmonary bypass circuit during coronary revascularization surgery. J Card Surg 12 (1997) 190-197
2. Aldea G.S., Soltow L.O., Chandler W.L., et al. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits. J Thorac Cardiovasc Surg 123 (2002) 742-755
3. Lindholm L., Westerberg M., Bengtsson A., et al. A closed perfusion system with heparin coating and centrifugal pump improves cardiopulmonary bypass biocompatibility in elderly patients. Ann Thorac Surg 78 (2004) 2131-2138
4. Westerberg M., Bengtsson A., and Jeppsson A. Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response. Ann Thorac Surg 78 (2004) 54-59
5. Videm V., Svennevig J.L., Fosse E., et al. Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations. J Thorac Cardiovasc Surg 103 (1992) 806-813
6. Pekna M., Hagman L., Halden E., et al. Complement activation during cardiopulmonary bypass: Effects of immobilized heparin. Ann Thorac Surg 58 (1994) 421-424
7. Fosse E., Moen O., Johnson E., et al. Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg 58 (1994) 472-477
8. Ovrum E., Mollnes T.E., Fosse E., et al. High and low heparin dose with heparin-coated cardiopulmonary bypass: Activation of complement and granulocytes. Ann Thorac Surg 60 (1995) 1755-1761
9. Aldea G.S., Doursounian M., O'Gara P., et al. Heparin-bonded circuits with a reduced anticoagulation protocol in primary CABG: A prospective, randomized study. Ann Thorac Surg 62 (1996) 410-417
10. Aldea G.S., O'Gara P., Shapira O.M., et al. Effect of anticoagulation protocol on outcome in patients undergoing CABG with heparin-bonded cardiopulmonary bypass circuits. Ann Thorac Surg 65 (1998) 425-433
11. Spiess B.D., Vocelka C., Cochran R.P., et al. Heparin-coated bypass circuits (Carmeda) suppress the release of tissue plasminogen activator during normothermic coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 12 (1998) 299-304
12. Greilich P.E., Brouse C.F., Whitten C.W., et al. Antifibrinolytic therapy during cardiopulmonary bypass reduces proinflammatory cytokine levels: A randomized, double-blind, placebo-controlled study of epsilon-aminocaproic acid and aprotinin. J Thorac Cardiovasc Surg 126 (2003) 1498-1503
13. Corcoran T.B., Engel A., Sakamoto H., et al. The effects of propofol on lipid peroxidation and inflammatory response in elective coronary artery bypass grafting. J Cardiothorac Vasc Anesth 18 (2004) 592-604
14. Bourbon A., Vionnet M., Leprince P., et al. The effect of methylprednisolone treatment on the cardiopulmonary bypass-induced systemic inflammatory response. Eur J Cardiothorac Surg 26 (2004) 932-938
15. Brooker R.F., Brown W.R., Moody D.M., et al. Cardiotomy suction: A major source of brain lipid emboli during cardiopulmonary bypass. Ann Thorac Surg 65 (1998) 1651-1655
16. Anderson R.E., Hansson L.O., Liska J., et al. The effect of cardiotomy suction on the brain injury marker S100beta after cardiopulmonary bypass. Ann Thorac Surg 69 (2000) 847-850
17. Philippou H., Adami A., Davidson S.J., et al. Tissue factor is rapidly elevated in plasma collected from the pericardial cavity during cardiopulmonary bypass. Thromb Haemost 84 (2000) 124-128
18. Svenmarker S., and Engstrom K.G. The inflammatory response to recycled pericardial suction blood and the influence of cell-saving. Scand Cardiovasc J 37 (2003) 158-164
19. Spanier T., Tector K., Schwartz G., et al. Endotoxin in pooled pericardial blood contributes to the systemic inflammatory response during cardiac surgery. Perfusion 15 (2000) 427-431
20. Reents W., Babin-Ebell J., Misoph M.R., et al. Influence of different autotransfusion devices on the quality of salvaged blood. Ann Thorac Surg 68 (1999) 58-62
21. Kincaid E.H., Jones T.J., Stump D.A., et al. Processing scavenged blood with a cell saver reduces cerebral lipid microembolization. Ann Thorac Surg 70 (2000) 1296-1300
22. Kaza A.K., Cope J.T., Fiser S.M., et al. Elimination of fat microemboli during cardiopulmonary bypass. Ann Thorac Surg 75 (2003) 555-559
23. Amand T., Pincemail J., Blaffart F., et al. Levels of inflammatory markers in the blood processed by autotransfusion devices during cardiac surgery associated with cardiopulmonary bypass circuit. Perfusion 17 (2002) 117-123
24. Jewell A.E., Akowuah E.F., Suvarna S.K., et al. A prospective randomised comparison of cardiotomy suction and cell saver for recycling shed blood during cardiac surgery. Eur J Cardiothorac Surg 23 (2003) 633-636
25. Serrick C.J., Scholz M., Melo A., et al. Quality of red blood cells using autotransfusion devices: A comparative analysis. J Extra Corpor Technol 35 (2003) 28-34
26. Ishida K., Gohara T., Kawata R., et al. Are serum S100beta proteins and neuron-specific enolase predictors of cerebral damage in cardiovascular surgery?. J Cardiothorac Vasc Anesth 17 (2003) 4-9
27. Baggiolini M., Walz A., and Kunkel S.L. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84 (1989) 1045-1049
28. Smith W.B., Gamble J.R., Clark-Lewis I., et al. Interleukin-8 induces neutrophil transendothelial migration. Immunology 72 (1991) 65-72
29. Franke A., Lante W., Fackeldey V., et al. Pro-inflammatory cytokines after different kinds of cardiothoracic surgical procedures: Is what we see what we know?. Eur J Cardiothorac Surg 28 (2005) 569-575
30. Matsuzaki K., Hiramatsu Y., Homma S., et al. Sivelestat reduces inflammatory mediators and preserves neutrophil deformability during simulated extracorporeal circulation. Ann Thorac Surg 80 (2005) 611-617
31. Sablotzki A., Friedrich I., Muhling J., et al. The systemic inflammatory response syndrome following cardiac surgery: Different expression of proinflammatory cytokines and procalcitonin in patients with and without multiorgan dysfunctions. Perfusion 17 (2002) 103-109
32. Devaney J.M., Greene C.M., Taggart C.C., et al. Neutrophil elastase upregulates interleukin-8 via toll-like receptor 4. FEBS Lett 544 (2003) 129-132
33. Johnsson P., Blomquist S., Luhrs C., et al. Neuron-specific enolase increases in plasma during and immediately after extracorporeal circulation. Ann Thorac Surg 69 (2000) 750-754
34. Grocott H.P., Croughwell N.D., Amory D.W., et al. Cerebral emboli and serum S100beta during cardiac operations. Ann Thorac Surg 65 (1998) 1645-1649
35. Jonsson H., Johnsson P., Alling C., et al. S100beta after coronary artery surgery: Release pattern, source of contamination, and relation to neuropsychological outcome. Ann Thorac Surg 68 (1999) 2202-2208
36. Anderson R.E., Hansson L.O., Nilsson O., et al. Increase in serum S100A1-B and S100BB during cardiac surgery arises from extracerebral sources. Ann Thorac Surg 71 (2001) 1512-1517